Description of a flow cytometry approach based on SYBR-14 staining for the assessment of DNA content, cell cycle analysis, and sorting of living normal and neoplastic cells

Experimental and Molecular Pathology

Volumn 76, Issue 1, 2004, Pages 29-36

  Nunez, R ^a   Garay, N ^a   Villafane, C ^a   Bruno, A ^a   Lindgren, V ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Aneuploidy; Breast cancer; Cell lines; Colon cancer; Polyploidy; Sorting; SYBR 14

Indexed keywords

DYE; PROPIDIUM IODIDE; SYBR 14; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; CELL CYCLE; CELL SELECTION; CELL VIABILITY; CONTROLLED STUDY; DIPLOIDY; DNA CONTENT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAMMAL CELL; STAINING; TETRAPLOIDY;

MAMMALIA;

EID: 0347301682     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2003.10.004     Document Type: Article

References (28)

1. Ando T., Kawabe T., Ohara H., Ducommun B., Itoh M., Okamoto T. Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. J. Biol. Chem. 276(46):2001;42971-42977.
2. Armas-Portela R., Parrales M.A., Albar J.P., Martinez-A C., Avila J. Distribution and characteristics of betaII tubulin-enriched microtubules in interphase cells. Exp. Cell Res. 248(2):1999;372-380.
3. Brunner N., Spang-Thomsen M., Vindelov L., Nielsen A., Engelholm S.A., Svenstrup B. Dose-dependent effect of 17 beta-estradiol determined by growth curves and flow cytometric DNA analysis of a human breast carcinoma (T61) grown in nude mice. Exp. Cell Biol. 53(4):1985;220-232.
4. Burstyn-Cohen T., Kalcheim C. Association between the cell cycle and neural crest delamination through specific regulation of G1/S transition. Dev. Cell. 3(3):2002;383-395. (Sept.).
5. Carbonari M., Tedesco T., Fiorilli M. A unified procedure for conservative (morphology) and integral (DNA and immunophenotype) cell staining for flow cytometry. Cytometry. 44(2):2001;120-125.
6. Chalah T., Brillard J.P. Comparison of assessment of fowl sperm viability by eosin-nigrosin and dual fluorescence (SYBR-14/PI). Theriogenology. 50:1998;487-931.
7. Chang J., Clark G.M., Allred D.C., Mohsin S., Chamness G., Elledge R.M. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. 97(3):2003;545-553. (Feb. 1).
8. Futreal P.A., Cochran C., Marks J.R., Iglehart J.D., Zimmerman W., Barrett J.C., Wiseman R.W. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line. Cancer Res. 54(7):1994;1791-1794. (Apr. 1).
9. Garner D.L., Johnson L.A. Viability assessment of mammalian sperm using SYBR-14 and propidium iodide. Biol. Reprod. 53:1995;276-284.
10. Goldwasser F., Shimizu T., Jackman J., Hoki Y., O'Connor P.M., Kohn K.W., Pommier Y. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells. Cancer Res. 56(19):1996;4430-4437.
11. Hall L.L., Th'ng J.P., Guo X.W., Teplitz R.L., Bradbury E.M. A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation. Cancer Res. 56(15):1996;3551-3559. (Aug. 1).
12. Juan G., Hernando E., Cordon-Cardo C. Separation of live cells in different phases of the cell cycle for gene expression analysis. Cytometry. 49(4):2002;170-175.
13. Krug H. Cell cycle and catamnesis in breast cancer. Cytophotometric studies. Arch. Gynecol. Obstet. 245(1-4):1989;651.
14. Krug H., Schonfelder M. Impulse cytophotometry and catamnesis in breast neoplasms. Acta Histochem., Suppl. 30:1984;117-127.
15. Lasfargues E.Y., Coutinho W.G., Dion A.S. A human breast tumor cell line (BT-474) that supports mouse mammary tumor virus replication. In Vitro. 15(9):1979;723-729. (Sept.).
16. Matzke M.A., Florian Mette M., Kanno T., Matzke A.J. Does the intrinsic instability of aneuploid genomes have a causal role in cancer? Trends Genet. 19(5):2003;253-256. (May).
17. Nakopoulou L., Tsirmpa I., Giannopoulou I., Trafalis D., Katsarou S., Davaris P. Aneuploidy of chromosome 20 in invasive breast cancer correlates with poor outcome. Cancer Genet. Cytogenet. 134(2):2002;127-132. (Apr. 15).
18. Nunez R. DNA measurement and cell cycle analysis by flow cytometry. Curr. Issues Mol. Biol. 3(3):2001;67-70.
19. Osborne C.K., Hobbs K., Trent J.M. Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res. Treat. 9(2):1987;111-121.
20. Pinto A.E., Andre S., Mendonca E., Silva G., Soares J. Overall survival in advanced breast cancer: relevance of progesterone receptor expression and DNA ploidy in fine-needle aspirates of 392 patients. Int. J. Biol. Markers. 18(1):2003;7-12. (Jan.-Mar.).
21. Reddel R.R., Hedley D.W., Sutherland R.L. Cell cycle effects of iron depletion on T-47D human breast cancer cells. Exp. Cell Res. 161(2):1985;277-284. (Dec.).
22. Saunders W., Hornack D., Lengyel V., Deng C. The Saccharomyces cerevisiae kinesin-related motor Kar3p acts at preanaphase spindle poles to limit the number and length of cytoplasmic microtubules. J. Cell Biol. 137(2):1997;417-431.
23. Sennerstam R., Auer G. Polyploidization by means of endoduplication in a human breast cancer cell line. Anal. Quant. Cytol. Histol. 15(5):1993;303. (Oct.).
24. Sotiriou C., Powles T.J., Dowsett M., Jazaeri A.A., Feldman A.L., Assersohn L., Gadisetti C., Libutti S.K., Liu E.T. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res. 4(3):2002;R3. (Epub 2002 Mar.).
25. Tsutsui S., Ohno S., Murakami S., Kataoka A., Kinoshita J., Hachitanda Y. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers. Oncol. Rep. 9(4):2002;793-799. (Jul.-Aug.).
26. Verma R., Babu A. Human Chromosomes: Principles and Techniques. 1995;McGraw-Hill, New York.
27. Wang C.S., Goulet F., Lavoie J., Drouin R., Auger F., Champetier S., Germain L., Tetu B. Establishment and characterization of a new cell line derived from a human primary breast carcinoma. Cancer Genet. Cytogenet. 120(1):2000;58-72. (Jul. 1).
28. Wolf K.W., Mentzel M., Mendoza A.S. Treatment with the anti-tumor drugs, cis-platin and mafosfamide, does not affect the structure of prekinetochores in a human breast cancer cell line. An immunofluorescence study using human anti-centromere autoantibodies. Anat. Anz. 178(5):1996;425-432. (Oct.).